These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7165279)

  • 21. Differential variations of sensitivities of TNP-modified lymphoma cells to lysis by cytotoxic lymphocytes and by antibodies.
    Bischoff P; Maugras M; Oth D
    Immunol Lett; 1982 Feb; 4(2):107-11. PubMed ID: 7061115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unresponsiveness in hapten-specific cytotoxic lymphocytes. II. Ability of various TNP-congeners to induce unresponsiveness after repeated treatments beginning at birth.
    Butler LD; Miller SD; Claman HN
    J Immunol; 1982 May; 128(5):1963-7. PubMed ID: 6977577
    [No Abstract]   [Full Text] [Related]  

  • 24. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
    Mohan K; Moulin P; Stevenson MM
    J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid.
    Kunin S; Gallily R
    Immunology; 1983 Feb; 48(2):265-72. PubMed ID: 6600441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model.
    Trop S; Samsonov D; Gotsman I; Alper R; Diment J; Ilan Y
    Hepatology; 1999 Mar; 29(3):746-55. PubMed ID: 10051476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self.
    Fujiwara H; Shearer GM
    J Immunol; 1980 Mar; 124(3):1271-6. PubMed ID: 6965689
    [No Abstract]   [Full Text] [Related]  

  • 32. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides.
    Kohler J; Hartmann U; Grimm R; Pflugfelder U; Weltzien HU
    J Immunol; 1997 Jan; 158(2):591-7. PubMed ID: 8992972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice.
    Radzikowski C; Rygaard J; Budzynski W; Stenvang JP; Schou M; Vangsted A; Zeuthen J
    APMIS; 1994 Jul; 102(7):481-8. PubMed ID: 7917216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell surface modifications with trifluoromethyl dinitrophenyl-soluble protein conjugates: immunogenic role of noncovalently bound hapten.
    Bischoff P; Maugras M; Poignant S; Oth D
    Int Arch Allergy Appl Immunol; 1984; 75(1):20-6. PubMed ID: 6611313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The attacker: target-cell ratio and serum effects on in vitro cell-mediated immunity.
    Mantovani A; Veechi A; Spreafico F
    J Natl Cancer Inst; 1975 Aug; 55(2):483-4. PubMed ID: 1159829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oscillations of IgM antibody affinity at the level of single immunocytes.
    Pini C; Di Felice G; Neri R; Mancini C; Vicari G; Doria G
    J Immunol; 1980 Sep; 125(3):1349-54. PubMed ID: 6157726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cellular immunity in an experimental ascites tumor: tumor immunostimulation mediated by splenic lymphocytic cells].
    García Villarrubia V; Moreno Koch MC
    Rev Esp Oncol; 1981; 28(2):169-94. PubMed ID: 7052966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.